Join the Class Action Against Agenus Inc.
The Gross Law Firm has a vital message for all shareholders of Agenus Inc. (NASDAQ: AGEN). If you've purchased shares during the class period, we encourage you to get in touch with us for assistance and guidance. It’s essential for every investor to understand their legal rights and the options available to them in situations like this.
Details of the Class Period
The class period for this action extends from January 23, 2023 to July 17, 2024. Shareholders who bought shares within this period may be affected by serious claims involving misleading information released by the company. We invite you to join us in the pursuit of justice and appropriate compensation for any losses you've experienced.
Impact of Allegations on Investors
Claims against Agenus Inc. suggest that during the class period, the company issued misleading statements about their combination therapy involving botensilimab and balstilimab. This may have resulted in unrealistic expectations about the clinical results and future potential of these treatments. Our legal team is convinced that the public was led astray regarding these therapies' effectiveness, and it’s important to bring this to light for all investors.
Understanding the Claims
Understanding the main allegations is crucial. The complaint points out that the defendants did not disclose potential risks and limitations related to these therapies, resulting in a misleading representation of their success. As a shareholder, grasping these claims will help you make informed choices about your investment.
How to Register
To secure your position in this class action, we strongly encourage you to complete the registration process. You don’t need to be a lead plaintiff; registering simply shows your interest in participating and allows you to stay updated on the case's developments.
What to Expect After Registration
Once you register, you'll gain access to a portfolio monitoring tool that keeps you informed about the case's progress. It's a useful way to stay engaged and prepared for any necessary actions as a shareholder.
The Importance of Acting Promptly
The deadline to take action in this case is November 5, 2024. Acting promptly is crucial regarding your rights as an investor. We strongly encourage all shareholders not to postpone registering, as delays could affect your potential recovery.
Why Choose The Gross Law Firm?
At The Gross Law Firm, our mission is straightforward: to safeguard the rights of investors who have suffered losses due to deceptive practices. We are committed to ensuring that companies operate honestly and that shareholders receive compensation for any wrongdoings. Our team has the expertise to navigate the complexities of class action procedures, and we’re here to support you every step of the way.
Contact Information
If you’re ready to register or if you have questions about the class action against Agenus Inc., please reach out to us using the contact details below:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is the class action regarding Agenus Inc.?
This class action involves allegations of misleading statements made by Agenus, which have impacted the investments of shareholders.
How do I know if I am eligible to join?
If you bought shares of Agenus between January 23, 2023, and July 17, 2024, you could be eligible to participate in the class action.
What do I need to do to register?
To register, simply contact The Gross Law Firm and provide the necessary details about your investments.
Is there a cost to participate?
No, participating in this class action does not involve any cost or obligation on your part.
What will happen if I register?
Once you register, you will start receiving updates about the case and become involved in efforts to claim damages resulting from the misleading actions of Agenus.
